Product interest request form

Thank you for your interest in MiniMed diabetes products and services. Please complete the items below so that we may provide you helpful information regarding our diabetes therapies.

indicates a required field.

Are you an existing MiniMed customer?
This field is required.

Check your upgrade eligibility

Follow these 3 simple steps:

  1. Sign into your account at www.diabetes.shop/devices
  2. Under Devices and products, select the “Check upgrade eligibility” button.
  3. See which program you're eligible for and then submit an upgrade request!

Check eligibility or upgrade >
This field is required.
This field is required.
This field is required.

You indicated that you’re not using insulin to manage your diabetes. Our insulin pumps are approved for the continuous delivery of insulin, so this device may not be a good fit for you at this time.

We have other resources that may be helpful for you:


If your circumstances change, please check back with us and we’d be happy to discuss therapy options that may fit your needs.

You indicated that you’re not using insulin to manage your diabetes. Our insulin pumps are approved for the continuous delivery of insulin, so this device may not be a good fit for you at this time.

We have other resources that may be helpful for you:


If your circumstances change, please check back with us and we’d be happy to discuss therapy options that may fit your needs.
This field is required.

Thank you for being a MiniMed customer. Please sign in to your Diabetes.shop account to see the upgrade options available for you. Submit the Request form within your account and you will be notified about next steps to upgrade.
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.
*
This field is required.

This form is for customers in the Unites States only. For more information about our products in your region please see our list of international locations.

How can we communicate with you?
This field is required.

I have read and understood the terms of this marketing authorization. I authorize Medtronic to use my protected health information for the purposes described in the authorization.

HIPAA MARKETING AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION

MiniMed* respects the privacy of all our customers. With your permission, we may use your protected health information, including your contact information and health-related data, for marketing purposes, promotional offers, survey opportunities, and advertising that we think may be of interest to you. We may also share your information with MiniMed representatives and contractors.  

Please note that this Authorization is optional, and you may refuse to opt in.  If you do not want to opt in, it will not affect your treatment, health insurance eligibility, or benefits, and you will not be stopped or prevented from accessing the CareLinkTM Personal system, or other MiniMed products, mobile apps, or services. You will be provided with a copy of this Authorization after it is acknowledged.

This Authorization will expire ten (10) years from the date you submit this authorization online but may expire sooner if required by applicable law, or if you remove it by following one of the methods below:

    1. Email takecontrol@medtronic.com
    2. Sign in to the Profile page and update your communication preferences
        at www.Diabetes.shop/communication
    3. Contact Customer Service Center at 800-646-4633

Opting out will not affect actions MiniMed has already taken based on this Authorization. Information disclosed pursuant to this Authorization may be re-disclosed by the recipient of the information and may no longer be protected by federal privacy standards. If you have additional questions about this Authorization, please contact our Customer Service Center at 800-646-4633 or by email at takecontrol@medtronic.com.

Please review our Notice of Privacy Practices and Privacy Statement or contact our support team to get details on how MiniMed processes your personal data, the involvement of affiliates and third-party data processors, cross-border transfer, and your rights as a data subject.

*MiniMed Distribution Corp. and Medtronic MiniMed, Inc. are “Medtronic Diabetes”
This field is required.

I agree to receive phone calls and/or artificial prerecorded marketing voice messages sent from or on behalf of MinMed using automated technology at the phone number(s) I have provided.

CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS

You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of MiniMed Distribution Corp. and its business associate MiniMed, Inc. (collectively “Medtronic Diabetes”), concerning the marketing, advertising and/or offers of sale of MiniMed products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for MiniMed to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) e-mailing takecontrol@medtronic.com; or (ii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/communication).
This field is required.

I agree to receive marketing SMS text communications using automated technology sent from or on behalf of MiniMed at the mobile phone number(s) I have provided (message frequency may vary).

CONSENT FOR RECEIPT OF TEXT COMMUNICATIONS

You consent to receiving text messages at the phone number(s) submitted above using automated technology from or on behalf of MiniMed Distribution Corp. and its business associate MiniMed, Inc. (collectively “Medtronic Diabetes”), concerning the marketing, advertising and/or offers of sale of MiniMed products, therapies and services. You also certify that you are (a) age 18 and older and (b) authorizing and consenting to use of the information provided for MiniMed to contact you. Your consent is not a condition for purchase. Airtime, message and data rates may apply. You may opt out at any time by (i) texting "STOP" in return to a text; (ii) sending an email to takecontrol@medtronic.com; or (iii) signing into your myHome profile and updating your communication preferences (www.diabetes.shop/communication).
This field is required.

If you arrived on this site via a social media platform, by submitting this form you agree that Medtronic Diabetes may share your visit to this site with that platform. This information may be used and/or re-disclosed by the originating site under their own privacy practices. See our Privacy Policy for more information. Click here to request information without submitting this form.

Thank you!

We’ve received your request – we’ll be in touch with product information soon.

Oops!

Something went wrong. Please try again later.

Important Safety Information: MiniMedTM 780G system with SmartGuardTM technology with Instinct sensor, Simplera SyncTM sensor, and GuardianTM 4 sensor

The MiniMedTM 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose vales in the fluid under the skin.

The MiniMedTM 780G System includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM and GuardianTM 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.

WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.

WARNING: Do not use MiniMedTM 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of MiniMedTM 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including accessories and additional important safety information concerning indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.minimed.com/important-safety-information and the appropriate user guide at https://www.minimed.com/support/resources.

Important Safety Information: InPenTM system

The InPenTM system is a home- use reusable pen injector for single- patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self- injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient- specific criteria and targets. The InPenTM requires a prescription. For additional product and safety information, please consult the Instructions for Use and bit.ly/InPenRisks.